79 related articles for article (PubMed ID: 18680418)
1. High levels of resistance to fluoroquinolones among Clostridium difficile isolates in a Spanish hospital.
Sánchez-Somolinos M; Alcalá L; Peláez T; Marín M; Martín A; Catalán P; Bouza E
Clin Infect Dis; 2008 Sep; 47(6):818-22. PubMed ID: 18680418
[No Abstract] [Full Text] [Related]
2. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem.
Gerding DN
Clin Infect Dis; 2004 Mar; 38(5):646-8. PubMed ID: 14986247
[No Abstract] [Full Text] [Related]
3. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance.
Razavi B; Apisarnthanarak A; Mundy LM
Infection; 2007 Oct; 35(5):300-7. PubMed ID: 17885732
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile and fluoroquinolones: is there a link?
Weiss K
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566
[TBL] [Abstract][Full Text] [Related]
5. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.
Huang H; Weintraub A; Fang H; Nord CE
Scand J Infect Dis; 2009; 41(2):158-9. PubMed ID: 18846478
[No Abstract] [Full Text] [Related]
6. Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease.
Patel NS
BJU Int; 2007 Jun; 99(6):1333-4. PubMed ID: 17233799
[No Abstract] [Full Text] [Related]
7. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
[TBL] [Abstract][Full Text] [Related]
8. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
Blondeau JM
J Antimicrob Chemother; 2009 Feb; 63(2):238-42. PubMed ID: 19028718
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing.
Joost I; Speck K; Herrmann M; von Müller L
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S13-8. PubMed ID: 19303562
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
Poilane I; Fantinato C; Cruaud P; Collignon A
Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
[TBL] [Abstract][Full Text] [Related]
11. Emergence of reduced susceptibility to metronidazole in Clostridium difficile.
Baines SD; O'Connor R; Freeman J; Fawley WN; Harmanus C; Mastrantonio P; Kuijper EJ; Wilcox MH
J Antimicrob Chemother; 2008 Nov; 62(5):1046-52. PubMed ID: 18693234
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital].
Cattoir V; Ould-Hocine ZF; Legrand P
Pathol Biol (Paris); 2008; 56(7-8):407-11. PubMed ID: 18845403
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.
Balassiano IT; Miranda KR; Boente RF; Pauer H; Oliveira IC; Santos-Filho J; Amorim EL; Caniné GA; Souza CF; Gomes MZ; Ferreira EO; Brazier JS; Domingues RM
Anaerobe; 2009 Jun; 15(3):61-4. PubMed ID: 19154793
[TBL] [Abstract][Full Text] [Related]
14. Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients.
Chang KC; Leung CC; Yew WW; Lam FM; Ho PL; Chau CH; Cheng VC; Yuen KY
Int J Tuberc Lung Dis; 2009 Mar; 13(3):341-6. PubMed ID: 19275794
[TBL] [Abstract][Full Text] [Related]
15. Emergence of quinolone-resistant Shigella dysenteriae type 1 in Canada.
Can Commun Dis Rep; 2005 Oct; 31(19):193-7. PubMed ID: 16200675
[No Abstract] [Full Text] [Related]
16. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
Gagliotti C; Buttazzi R; Sforza S; Moro ML;
J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
Hames A; Perry JD; Gould FK
J Antimicrob Chemother; 2009 May; 63(5):1076. PubMed ID: 19240074
[No Abstract] [Full Text] [Related]
18. [First Danish case of Clostridium difficile ribotype 027].
Søes LM; Brock I; Torpdahl M; Persson S; Christensen KM; Kemp M; Olsen KE
Ugeskr Laeger; 2009 May; 171(19):1579-80. PubMed ID: 19419637
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
[TBL] [Abstract][Full Text] [Related]
20. Editorial commentary: Vancomycin for your mother, metronidazole for your mother-in-law.
Read RC
J Infect; 2007 Dec; 55(6):483. PubMed ID: 17988743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
